46 results
424B3
CTCX
Carmell Corp - Ordinary Shares
5 Jun 24
Prospectus supplement
6:06am
satisfaction with the aesthetic results of our products.
In order to generate repeat business from consumers, our consumers must be satisfied … to such payers’ satisfaction. Such studies might require us to commit a significant amount of management time and financial and other resources. Our
8-K
EX-10.1
CTCX
Carmell Corp - Ordinary Shares
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Subject to satisfaction of the covenants and conditions
8-K
EX-10.1
w3cwmkmdegtlu06uwmgb
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K
EX-99.1
q5zn7raa4crw2 yw2q
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
8-K/A
EX-99.2
khdrghcjnxyz59
14 Aug 23
Completion of Acquisition or Disposition of Assets
5:55pm
8-K
EX-3.1
nfahi
14 Aug 23
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
7:01am
8-K
EX-10.1
on8ioxbhl6
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
8-K
b039o
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
8-K
EX-99.2
n9gbk u3qmwo6
20 Jul 23
Entry into a Material Definitive Agreement
5:21pm
425
t2mqu3jibst1m
27 Jun 23
Business combination disclosure
8:28am
8-K
EX-99.1
zreog1v
27 Jun 23
Other Events
8:26am
424B3
n65n96qzw45hjpa
23 Jun 23
Prospectus supplement
4:47pm